Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kelvin H.-V. Tan"'
Autor:
Alan J. Knox, David Stableforth, Pauline Hyman-Taylor, Kelvin H.-V. Tan, Sarah Lewis, Alan R. Smyth, Michael Mulheran
Publikováno v:
Antimicrobial Agents and Chemotherapy. 50:2293-2299
We undertook assessment of hearing in patients with cystic fibrosis who were taking part in a large randomized controlled trial of once- versus three-times-daily tobramycin for pulmonary exacerbations of cystic fibrosis (the TOPIC study). All patient
Autor:
Michael Mulheran, Pauline Hyman-Taylor, Alan J. Knox, Kelvin H.-V. Tan, Sarah Lewis, Alan R. Smyth, David Stableforth
Publikováno v:
The Lancet. 365:573-578
Summary Background Intravenous tobramycin (three-times daily) is widely used for pulmonary exacerbations in patients with cystic fibrosis who have chronic Pseudomonas aeruginosa infection. We undertook a double-blind, randomised controlled trial to a
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 167:819-823
lean mass, of which 70% is body water and the remainder muscle. After intravenous administration, aminoglycosides distribute rapThe potential of aminoglycoside antibiotics to cause ototoxic idly throughout the extracellular fluid compartment, with pe
Publikováno v:
The Lancet, 365(9473), 1767-1768. ELSEVIER SCIENCE INC
Publikováno v:
Pediatric Pulmonology. 33:406-406
Publikováno v:
Pediatric Pulmonology. 33:165-165